http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105582548-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate | 2014-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105582548-B |
| titleOfInvention | Application of human UBA2 gene and related medicine thereof |
| abstract | The invention discloses an application of a human UBA2 gene and a related medicine thereof. The invention discloses the use of human UBA2 gene in tumor treatment, tumor diagnosis and medicine preparation. The invention further constructs human UBA2 gene small interfering RNA, a human UBA2 gene interfering nucleic acid construct, a human UBA2 gene interfering lentivirus and discloses the application of the human UBA2 gene small interfering RNA and the human UBA2 gene interfering lentivirus. The siRNA or the nucleic acid construct containing the siRNA sequence and the lentivirus provided by the invention can specifically inhibit the expression of the human UBA2 gene, particularly the lentivirus can efficiently infect target cells, efficiently inhibit the expression of the UBA2 gene in the target cells, further inhibit the growth of tumor cells and promote the apoptosis of the tumor cells, and have important significance in tumor treatment. |
| priorityDate | 2014-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 205.